Hans J. W. de Haard
Corporate Officer/Principal presso University of Utrecht
Profilo
Hans J. W. de Haard ha fondato argenx SE e AgomAb Therapeutics NV. Attualmente ricopre la posizione di direttore scientifico presso argenx SE. È anche professore all'Universit de Franche-Comt e professore di Immunologia camaleonte all'Università di Utrecht. In precedenza è stato scienziato presso Unilever NV e direttore dello sviluppo tecnologico presso Ablynx NV. Il Dr. De Haard ha ricevuto un dottorato e una laurea all'Università di Maastricht.
Posizioni attive di Hans J. W. de Haard
Società | Posizione | Inizio |
---|---|---|
University of Utrecht | Corporate Officer/Principal | - |
Université de Franche-Comté | Corporate Officer/Principal | - |
Precedenti posizioni note di Hans J. W. de Haard
Società | Posizione | Fine |
---|---|---|
AgomAb Therapeutics NV
AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Founder | - |
ARGENX SE | Founder | - |
UNILEVER N.V. | Chief Tech/Sci/R&D Officer | - |
ABLYNX | Chief Tech/Sci/R&D Officer | - |
Formazione di Hans J. W. de Haard
Maastricht University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ARGENX SE | Health Technology |
Aziende private | 3 |
---|---|
Unilever NV
Unilever NV Food DistributorsDistribution Services Unilever NV engages in the production and marketing of consumer goods in the nutrition, hygiene, and personal care categories. It operates through the following segments: Beauty and Personal Care, Foods and Refreshment, and Home Care. The Beauty and Personal Care segment covers the sales of skin and hair care products, deodorants and oral care products. The Foods and Refreshment segment includes the sales of soups, bouillons, sauces, snacks, mayonnaise, salad dressings, margarines and spreads. The Home Care segment is in charge of the sales of home care products such as powders, liquids and capsules, soap bars, and a wide range of cleaning products. The company was founded on November 9, 1927 and is headquartered in Rotterdam, Netherlands. | Distribution Services |
Ablynx NV
Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
AgomAb Therapeutics NV
AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Commercial Services |
- Borsa valori
- Insiders
- Hans J. W. de Haard